Compare SJT & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SJT | KRMD |
|---|---|---|
| Founded | 1980 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.0M | 288.6M |
| IPO Year | N/A | N/A |
| Metric | SJT | KRMD |
|---|---|---|
| Price | $5.64 | $5.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.88 |
| AVG Volume (30 Days) | ★ 186.4K | 182.0K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $24,557.00 | ★ $39,070,637.00 |
| Revenue This Year | N/A | $23.36 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $3.77 | $1.86 |
| 52 Week High | $7.22 | $6.61 |
| Indicator | SJT | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.08 | 53.42 |
| Support Level | $5.24 | $5.55 |
| Resistance Level | $5.52 | $6.61 |
| Average True Range (ATR) | 0.20 | 0.33 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 46.94 | 29.97 |
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).